Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 79

1.

YAP-Mediated Mechanotransduction in Skeletal Muscle.

Fischer M, Rikeit P, Knaus P, Coirault C.

Front Physiol. 2016 Feb 16;7:41. doi: 10.3389/fphys.2016.00041. eCollection 2016. Review.

2.

ZEB1 turns into a transcriptional activator by interacting with YAP1 in aggressive cancer types.

Lehmann W, Mossmann D, Kleemann J, Mock K, Meisinger C, Brummer T, Herr R, Brabletz S, Stemmler MP, Brabletz T.

Nat Commun. 2016 Feb 15;7:10498. doi: 10.1038/ncomms10498.

3.

Emerging role of Hippo pathway in gastric and other gastrointestinal cancers.

Kang W, Cheng AS, Yu J, To KF.

World J Gastroenterol. 2016 Jan 21;22(3):1279-88. doi: 10.3748/wjg.v22.i3.1279. Review.

4.

The interplay between centrosomes and the Hippo tumor suppressor pathway.

Bolgioni AF, Ganem NJ.

Chromosome Res. 2016 Jan;24(1):93-104. doi: 10.1007/s10577-015-9502-8.

PMID:
26582635
5.

Upregulation of miR-181c contributes to chemoresistance in pancreatic cancer by inactivating the Hippo signaling pathway.

Chen M, Wang M, Xu S, Guo X, Jiang J.

Oncotarget. 2015 Dec 29;6(42):44466-79. doi: 10.18632/oncotarget.6298.

6.

TAZ Protein Accumulation Is Negatively Regulated by YAP Abundance in Mammalian Cells.

Finch-Edmondson ML, Strauss RP, Passman AM, Sudol M, Yeoh GC, Callus BA.

J Biol Chem. 2015 Nov 13;290(46):27928-38. doi: 10.1074/jbc.M115.692285. Epub 2015 Oct 2.

PMID:
26432639
7.

Signaling in Fibrosis: TGF-β, WNT, and YAP/TAZ Converge.

Piersma B, Bank RA, Boersema M.

Front Med (Lausanne). 2015 Sep 3;2:59. doi: 10.3389/fmed.2015.00059. eCollection 2015. Review.

8.

Differential control of Yorkie activity by LKB1/AMPK and the Hippo/Warts cascade in the central nervous system.

Gailite I, Aerne BL, Tapon N.

Proc Natl Acad Sci U S A. 2015 Sep 15;112(37):E5169-78. doi: 10.1073/pnas.1505512112. Epub 2015 Aug 31.

9.

Prognostic Value of Yes-Associated Protein 1 (YAP1) in Various Cancers: A Meta-Analysis.

Sun Z, Xu R, Li X, Ren W, Ou C, Wang Q, Zhang H, Zhang X, Ma J, Wang H, Li G.

PLoS One. 2015 Aug 11;10(8):e0135119. doi: 10.1371/journal.pone.0135119. eCollection 2015.

10.

Hippo signaling is required for Notch-dependent smooth muscle differentiation of neural crest.

Manderfield LJ, Aghajanian H, Engleka KA, Lim LY, Liu F, Jain R, Li L, Olson EN, Epstein JA.

Development. 2015 Sep 1;142(17):2962-71. doi: 10.1242/dev.125807. Epub 2015 Aug 7.

11.

Emerging evidence on the role of the Hippo/YAP pathway in liver physiology and cancer.

Yimlamai D, Fowl BH, Camargo FD.

J Hepatol. 2015 Dec;63(6):1491-501. doi: 10.1016/j.jhep.2015.07.008. Epub 2015 Jul 28. Review.

PMID:
26226451
12.

Hippo Stabilises Its Adaptor Salvador by Antagonising the HECT Ubiquitin Ligase Herc4.

Aerne BL, Gailite I, Sims D, Tapon N.

PLoS One. 2015 Jun 30;10(6):e0131113. doi: 10.1371/journal.pone.0131113. eCollection 2015.

13.

The Hippo pathway promotes cell survival in response to chemical stress.

Di Cara F, Maile TM, Parsons BD, Magico A, Basu S, Tapon N, King-Jones K.

Cell Death Differ. 2015 Sep;22(9):1526-39. doi: 10.1038/cdd.2015.10. Epub 2015 Mar 13.

PMID:
26021298
14.

Podocyte-Specific Deletion of Yes-Associated Protein Causes FSGS and Progressive Renal Failure.

Schwartzman M, Reginensi A, Wong JS, Basgen JM, Meliambro K, Nicholas SB, D'Agati V, McNeill H, Campbell KN.

J Am Soc Nephrol. 2016 Jan;27(1):216-26. doi: 10.1681/ASN.2014090916. Epub 2015 May 26.

PMID:
26015453
15.

The interplay between TEAD4 and KLF5 promotes breast cancer partially through inhibiting the transcription of p27Kip1.

Wang C, Nie Z, Zhou Z, Zhang H, Liu R, Wu J, Qin J, Ma Y, Chen L, Li S, Chen W, Li F, Shi P, Wu Y, Shen J, Chen C.

Oncotarget. 2015 Jul 10;6(19):17685-97.

16.

A conserved MST1/2-YAP axis mediates Hippo signaling during lung growth.

Lin C, Yao E, Chuang PT.

Dev Biol. 2015 Jul 1;403(1):101-13. doi: 10.1016/j.ydbio.2015.04.014. Epub 2015 Apr 24.

PMID:
25912685
17.

A novel role for microRNA-129-5p in inhibiting ovarian cancer cell proliferation and survival via direct suppression of transcriptional co-activators YAP and TAZ.

Tan G, Cao X, Dai Q, Zhang B, Huang J, Xiong S, Zhang Yy, Chen W, Yang J, Li H.

Oncotarget. 2015 Apr 20;6(11):8676-86.

18.

The hippo pathway in heart development, regeneration, and diseases.

Zhou Q, Li L, Zhao B, Guan KL.

Circ Res. 2015 Apr 10;116(8):1431-47. doi: 10.1161/CIRCRESAHA.116.303311. Review.

19.

YAP regulates the expression of Hoxa1 and Hoxc13 in mouse and human oral and skin epithelial tissues.

Liu M, Zhao S, Lin Q, Wang XP.

Mol Cell Biol. 2015 Apr;35(8):1449-61. doi: 10.1128/MCB.00765-14. Epub 2015 Feb 17.

20.

Ski regulates Hippo and TAZ signaling to suppress breast cancer progression.

Rashidian J, Le Scolan E, Ji X, Zhu Q, Mulvihill MM, Nomura D, Luo K.

Sci Signal. 2015 Feb 10;8(363):ra14. doi: 10.1126/scisignal.2005735.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk